BioCrossroads recently appointed seven new board members and elevated two current members.
Cathy Langham, Langham Logistics president and CEO, and Alan Palkowitz, Indiana Bioscience Research Institute president and CEO, were named to BioCrossroads’s executive committee.
Langham, a board member since April, brings entrepreneurship experience and community connectivity to her new role. Palkowitz, who joined the board in 2021, has over three decades of expertise in drug discovery, development and leadership experience.
“These leadership changes are not only a reflection of our commitment to fostering growth and innovation within Indiana’s life sciences sector, but also help ensure we have the right vision and expertise as we work to fulfill our ambitious 10-year plan,” said Dan Peterson, BioCrossroads’s board chair, in a press release.
Peterson is the vice president of industry and government affairs at Cook Medical.
“Elevating seasoned leaders like Cathy Langham and Alan Palkowitz to our executive committee reinforces our capacity to drive forward initiatives that will solidify Indiana’s position as a global life sciences leader,” Peterson said.
BioCrossroads welcomed seven new members to its board of directors:
- Ryan Baehl, Labcorp Central Lab global head of operations
- Matt Connell, Ivy Tech vice president of health care
- Daniel Golden, Elanco Animal Health vice president and global head of research, discovery and breakthrough innovation
- David Ingram, IU Health system chief medical executive
- Jim Lancaster, Zimmer Biomet president of recon and global headquarters executive director
- Cory Lewis, INCOG BioPharma Services president and CEO
- Ron Penczek, Elevance Health chief accounting officer
The new members of the executive committee and board replace departing members.
“Each new board member brings expertise that complements our strategic goals, enhancing our capacity to foster innovation, expand life sciences manufacturing, nurture workforce development and elevate Indiana’s profile as a leader in life sciences,” Vince Wong, BioCrossroads’s president and CEO, said.
Indianapolis-based BioCrossroads works to advance Indiana’s life sciences industry. The organization connects corporate, academic and philanthropic partners. BioCrossroads facilitates investments in startups and educates through conferences, reports and market knowledge.
